Tool enables clinicians to plan and perform high-dose-rate (HDR) brachytherapy treatments for prostate cancer using real-time ultrasound guidance
PALO ALTO, Calif. - Varian Medical Systems (NYSE: VAR) has received an FDA 510(k) clearance for the latest version of its Vitesse(TM) real time planning for HDR brachytherapy which is used to plan and perform high-dose-rate (HDR), ultrasound-guided brachytherapy treatments for prostate cancer.
"This version of Vitesse reduces the number and ...This story is related to the following:Health, Medical and Dental Supplies and EquipmentSearch for suppliers of: Planning Software | Portable Medical X-Ray Equipment